Defunct Company
Total Trials
9
As Lead Sponsor
2
As Collaborator
7
Total Enrollment
2,016,449
NCT02620527
Concordance Between ctDNA Assay and FoundationOne
Phase: N/A
Role: Collaborator
Start: Nov 30, 2014
Completion: Dec 31, 2017
NCT03545321
RESPOND TO PREVENT: Stepwise Pharmacy Naloxone Study
Start: Jul 9, 2019
Completion: Nov 30, 2022
NCT04798521
TeleHepC Treatment Trial
Start: Jun 30, 2020
Completion: Jan 10, 2024
NCT06057181
Helix Research Network
Start: Sep 13, 2021
Completion: Sep 13, 2036
NCT05724667
An Evaluation of a Flippin' Pain Seminar Series
Start: Feb 15, 2022
Completion: Apr 1, 2022
NCT05813067
Herbal Nutraceutical Supplementation on Vasomotor Symptoms in Menopausal Women
Role: Lead Sponsor
Start: Dec 27, 2022
Completion: Apr 23, 2024
NCT06289907
Hot Flash and Night Sweat Virtual Study
Start: Jul 9, 2023
Completion: Jul 30, 2024
NCT05700994
Peer Engagement in Methamphetamine Harm-Reduction With Contingency Management (PEER-CM)
Start: Nov 13, 2023
Completion: Sep 30, 2026
NCT06354192
Precision Nudging for Hypertension Management: Observational Study
Start: May 1, 2024
Completion: Nov 1, 2026